Get started
Author

Constanze Hampel

Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian Cancer
2006 · Zhenfeng Duan, Rosemary Foster, et al. · Clinical Cancer Research · 251
Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies
2013 · Shahin Assefnia, Sivanesan Dakshanamurthy, et al. · Oncotarget · 71
PDF
Final analysis of a phase I/IIa study with CV9103, an intradermally administered prostate cancer immunotherapy based on self-adjuvanted mRNA.
2011 · H. Kübler, T. Maurer, et al. · Journal of Clinical Oncology · 31
Haematopoietic toxicity of radium-223 in patients with high skeletal tumour burden
2015 · C. Thomas, J. Beck, et al. · Nuklearmedizin - NuclearMedicine · 18
2640 Vinflunine maintenance treatment following first-line therapy of advanced urothelial carcinoma - results from the JASiMA trial
2015 · M. De Wit, P. De Geeter, et al. · European Journal of Cancer · 6
7046 POSTER Final Analysis of a Phase l/lla Study With CV9103, an Intradermally Administered Prostate Cancer Immunotherapy Based on Self Adjuvanted mRNA
2011 · H. Kübier, A. Stenzl, et al. · European Journal of Cancer · 5
Abstract A045: Cadherin-11, a common therapeutic target in poor prognosis malignancies and rheumatoid arthritis
2013 · Shahin Assefnia, Sivanesan Dakshanamurthy, et al. · Molecular Cancer Research
O11 Final analysis of a phase I/II study with CV9103: An intradermally administered prostate cancer vaccine based on self-adjuvanted mRNA (RNActive®)
2012 · H. Kübler, T. Maurer, et al. · European Urology Supplements
Deregulation of E2f-1 and chemosensitivity.
2004 · Constanze Hampel · OpenGrey (Institut de l'Information Scientifique et Technique)
Role of E2F-1 in chemosensitivity to minor groove binding agents
2000 · Hampel, C, Tolner, B, et al. · UCL Discovery (University College London)
Works count: 11
Citation count: 382
H-index: 5
I10-index: 4
Year
Topic
Type